CTVE.F Stock Overview
Provides revenue cycle consultative services and solutions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Certive Solutions Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0014 |
| 52 Week High | CA$0.028 |
| 52 Week Low | CA$0.0002 |
| Beta | 0.48 |
| 11 Month Change | -84.74% |
| 3 Month Change | n/a |
| 1 Year Change | -91.32% |
| 33 Year Change | -96.96% |
| 5 Year Change | -94.82% |
| Change since IPO | -99.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| CTVE.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 45.0% | 2.1% | 2.2% |
| 1Y | -91.3% | 8.2% | 31.6% |
Return vs Industry: CTVE.F underperformed the US Healthcare Services industry which returned 8.3% over the past year.
Return vs Market: CTVE.F underperformed the US Market which returned 31.7% over the past year.
Price Volatility
| CTVE.F volatility | |
|---|---|
| CTVE.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 9.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CTVE.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CTVE.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Tom Marreel | certivehealth.com |
Certive Solutions Inc. provides revenue cycle consultative services and solutions in the United States. It offers healthcare revenue cycle management services and management solutions. It is also involved in the selling and servicing a cybersecurity suite of products to the healthcare industry.
Certive Solutions Inc. Fundamentals Summary
| CTVE.F fundamental statistics | |
|---|---|
| Market cap | US$1.27m |
| Earnings (TTM) | -US$1.58m |
| Revenue (TTM) | US$1.30m |
1.0x
P/S Ratio-0.8x
P/E RatioIs CTVE.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CTVE.F income statement (TTM) | |
|---|---|
| Revenue | US$1.30m |
| Cost of Revenue | US$955.16k |
| Gross Profit | US$344.81k |
| Other Expenses | US$1.92m |
| Earnings | -US$1.58m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0089 |
| Gross Margin | 26.52% |
| Net Profit Margin | -121.51% |
| Debt/Equity Ratio | -50.4% |
How did CTVE.F perform over the long term?
See historical performance and comparison